OncoCyte Corporation (OCX)
NASDAQ: OCX · Real-Time Price · USD
2.750
+0.200 (7.84%)
Nov 20, 2024, 4:00 PM EST - Market closed
OncoCyte Market Cap
OncoCyte has a market cap or net worth of $46.30 million as of November 21, 2024. Its market cap has increased by 141.13% in one year.
Market Cap
46.30M
Enterprise Value
46.92M
1-Year Change
141.13%
Ranking
Category
Stock Price
$2.75
Market Cap Chart
Since January 4, 2016, OncoCyte's market cap has decreased from $228.70M to $46.30M, a decrease of -79.76%. That is a compound annual growth rate of -16.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 46.30M | 123.67% |
| Dec 29, 2023 | 20.70M | -45.67% |
| Dec 30, 2022 | 38.10M | -80.96% |
| Dec 31, 2021 | 200.10M | 24.52% |
| Dec 31, 2020 | 160.70M | 37.47% |
| Dec 31, 2019 | 116.90M | 108.38% |
| Dec 31, 2018 | 56.10M | -61.60% |
| Dec 29, 2017 | 146.10M | -27.82% |
| Dec 30, 2016 | 202.40M | -11.50% |
| Jan 4, 2016 | 228.70M | - |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CalciMedica | 45.63M |
| HCW Biologics | 45.39M |
| Actinium Pharmaceuticals | 45.39M |
| Serina Therapeutics | 45.26M |
| Reviva Pharmaceuticals Holdings | 45.15M |
| SCYNEXIS | 44.51M |
| Fortress Biotech | 44.23M |
| Xilio Therapeutics | 43.95M |